Protein consumption and diabetes mellitus: an overview.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to L J Hoffer.
Explore the source record for details and available documents.
Although mild abnormalities of amino acid metabolism frequently exist in conventionally treated insulin-dependent diabetes mellitus (IDDM), their physiologic and nutritional importance is uncertain. We tested whether a tendency toward body N loss can be either masked or revealed in insulin-treated IDDM by changing the level of protein in the diet. After adaptation to a protein-free diet adequate in all other nutrients, obligatory urinary N excretion of intensively treated IDDM subjects was significantly greater than normal, indicating an impaired ability to recycle endogenous amino acids during protein restriction. When the preceding diet was high in protein, urea N production after consumption of a mixed test meal matched the amount of N consumed for both normal and diabetic subjects. However, when the test meal was preceded by 5 d of protein restriction, conventionally treated IDDM subjects failed to adaptively reduce postprandial urea production as effectively as normal or intensively treated IDDM subjects. Thus, even during insulin treatment, the ability to maximally recycle endogenous amino acids is impaired in IDDM, as is the ability to adaptively increase dietary amino acid retention in response to protein restriction.
Urea production rate (Ra) is commonly measured using a primed continuous tracer urea infusion, but the accuracy of this method has not been clearly established in humans. We used intravenous infusions of unlabeled urea to assess the accuracy of this technique in normal, postabsorptive men under the following four different conditions: 1) tracer [13C]urea was infused under basal conditions for 12 h (control); 2) tracer [13C]urea was infused for 12 h, and unlabeled urea was infused from hours 4 to 12 at a rate twofold greater than the endogenous Ra ("step" infusion); 3) tracer [13C]urea was infused for 12 h, and unlabeled urea was infused from hours 4 to 8 ("pulse" infusion); and 4) tracer [13C]urea was infused for 9 h, and unlabeled alanine was infused at a rate of 120 mg.kg-1.h-1 (1.35 mmol.kg-1.h-1) from hours 4 to 9. Urea Ra was calculated using the isotopic steady-state equation (tracer infusion rate/tracer-to-tracee ratio), Steele's non-steady-state equation, and urinary urea excretion corrected for changes in total body urea. For each subject, endogenous urea Ra was measured at hour 4 of the basal condition, and the sum of this rate plus exogenous urea input was considered as "true urea input". Under control conditions, urea Ra at hour 4 was similar to that measured at hour 12. After 8-h step and 4-h pulse unlabeled urea infusions, Steele's non-steady-state equation underestimated true urea input by 22% (step) and 33% (pulse), whereas the nonisotopic method underestimated true urea input by 28% (step) and 10% (pulse). Similar conclusions were derived from the alanine infusion. These results indicate that, although Steele's non-steady-state equation and the nontracer method more accurately predict total urea Ra than the steady-state equation, they nevertheless seriously underestimate total urea Ra for as long as 8 h after a change in true urea Ra.
Explore the source record for details and available documents.
Eight normal subjects, four subjects with intensively treated insulin-dependent diabetes mellitus (IDDM), and six subjects with conventionally treated IDDM consumed a test meal of 0.5 g protein and 10 kcal per kg body weight, first while adapted to a conventional diet high in protein, and then again after 5 days of dietary protein restriction. Metabolic N balance (N consumed minus urea production) and net protein utilization were measured over the 9 h after consumption of the test meal, as was recovery in urea of 15N from a tracer dose of [15N]alanine included in each test meal. After the first test meal, N balance and net protein utilization were similar and close to zero for all groups. After the second test meal, N balance and net protein utilization became positive for all groups (P < 0.05) but significantly less so (P < 0.05) for the conventionally treated than for the normal and intensively treated diabetic subjects. 15N recovery in urea was reduced for all groups after the second test meal (P < 0.05) but probably less effectively (P < 0.09) for the conventionally treated diabetic subjects. Metabolic adaptation to protein restriction may be less effective than normal in conventionally treated IDDM.
We tested whether expansion of the plasma leucine pool distorts leucine or valine tracer kinetics, causing errors in the derived values of whole body proteolysis. Seven normal adults received a 10-h primed-continuous tracer infusion of L-[5,5,5-2H3]leucine, L-[(1-13)C]valine, and L-[(1-13)C]threonine, during the final 7 h of which L-leucine was infused at a rate that more than tripled the plasma leucine concentration. Leucine, valine, and threonine rates of appearance were converted to a common value of whole body proteolysis on the basis of their concentrations in body proteins. The conversion of labeled leucine and valine to their corresponding branched-chain alpha-keto and alpha-hydroxy acids was also monitored. Before the unlabeled leucine infusion, postabsorptive whole body proteolysis was estimated similarly by the three tracers (approximately 180 mg protein.kg-1.h-1. The leucine infusion reduced proteolysis by an average of 21% (P < 0.006), as estimated by use of valine or threonine kinetics, and by 10% by use of leucine kinetics (P < 0.02). No delay in the conversion of valine to alpha-ketoisovalerate occurred during the leucine infusion. Thus all three tracers indicated similar postabsorptive rates of whole body proteolysis and a reduction of proteolysis during leucine administration, although the magnitude of the effect was underestimated with use of the leucine tracer.
We have investigated the effects of modifying the dose of thyroxine on resting energy expenditure (REE) and on the thermic effect of glucose (TEG) in 9 randomly recruited patients on chronic treatment with this hormone. The initial dose was changed twice in each patient at 6-8 wk intervals, aiming to have a normal, a slightly reduced, and a slightly elevated serum TSH concentration. A total of 27 dose points for each measured variable (3 per patient) were gathered. Dose changes were monitored with serum free T4, T3, and TSH. At the end of each dose period, low density lipoprotein and high density lipoprotein cholesterol, triglycerides, angiotensin converting enzyme, and sex hormone binding globulin were also measured, along with a systematic assessment of symptoms and signs. The investigators involved in the measurements were blinded to the dose of T4. Serum free T4 and TSH significantly correlated to the dose in each patient and in the whole group, whereas serum T3 levels were minimally affected by the dose and did not correlate with it, with free T4 or with TSH. This latter was below normal on 9 occasions, normal in 12, and above normal in 6. Serum free T4 and T3 remained within the normal range on all except 2 occasions. REE and TEG were normalized to fat-free mass (FFM). In each patient there was a significant negative correlation between REE and TSH. This correlation was maintained when all data were pooled (r2 = 0.64; P < 0.001). Also, initial REE and its change between the highest and the lowest thyroxine dose were significantly correlated with, respectively, initial serum TSH (r2 = 0.85; P < 0.001) and the change in serum TSH between the highest and the lowest dose of T4 (r2 = 0.67; P < 0.0065). REE decreased approximately 15% when TSH increased between 0.1 and 10 mU/L. In 6 of the 9 patients, TEG increased with the reduction of the dose, and higher values were associated with higher TSH levels but without reaching statistical significance (F = 2.852, P = 0.077). None of the other indices were significantly affected by the changes in dose. These results indicate that, in patients on chronic treatment with thyroxine, REE is significantly influenced by the dose of this hormone in a dose range encompassing serum TSH concentrations that are considered acceptable in the management of hypothyroid patients. In the absence of physiological or behavioral compensations, these changes in REE may be clinically relevant.
Explore the source record for details and available documents.
Humans lose weight when administered fluoxetine, an inhibitor of serotonin reuptake by nerve terminals. To determine whether increased energy expenditure contributes to this weight loss we admitted 20 nondepressed obese women to a metabolic unit where they were randomly assigned to 3 wk of a 1.76-MJ/d formula diet and either 60 mg fluoxetine/d or a placebo. Resting energy expenditure of the control subjects fell below normal after 5.6 +/- 0.6 d of energy restriction, whereas that of the fluoxetine-treated subjects increased by 4.4 +/- 1.8% (P < 0.005) within 3 d of commencing treatment. This increased resting energy expenditure then reversed and fell below normal after 9.8 +/- 0.9 d of energy restriction. Basal body temperature of the control subjects decreased insignificantly during the period of energy restriction, but that of the fluoxetine-treated subjects increased by 0.28 +/- 0.10 degrees C (P < 0.05) within 3 d of commencing diet and drug treatment. Urinary norepinephrine excretion and the serum triiodothyronine concentration decreased equally in both groups. Despite identical energy intakes and equal nitrogen balance, the fluoxetine-treated subjects lost weight faster than the control subjects during the final week of energy restriction (P < 0.05). We propose that serotonin reuptake inhibition increases energy expenditure by increasing basal body temperature.
We tested whether the primary or reciprocal pool models for whole-body leucine kinetics accurately depict human adaptation to protein deficiency and repletion in the fed state by comparing model-derived leucine oxidation with urea appearance calculated from urinary urea excretion and changes in the body urea pool. Five normal men consumed a control diet providing maintenance energy and 80 g protein/d for 5 days; this was followed by 7 days of an isoenergetic protein-free diet, and finally by a return to the original control diet for 5 days. At the end of each dietary period, urea appearance and leucine oxidation were measured during a 4-hour intravenous infusion of crystalline amino acids providing a total N to leucine N ratio similar to that in mixed body proteins. Primary pool-derived fed-state leucine oxidation decreased after adaptation to protein deficiency and remained low during refeeding (18.6 +/- 1.2, 13.2 +/- 1.1, and 15.0 +/- 1.8 mumol.kg-1.h-1, respectively, P < .01), in agreement with the physiologic prediction. A similar pattern occurred with the reciprocal pool model (24.4 +/- 2.7, 17.3 +/- 2.0, and 20.3 +/- 2.7 mumol.kg-1.h-1, P < .01) as well as with urea N appearance (3.06 +/- 0.32, 2.34 +/- 0.24, and 2.38 +/- 0.26 mmol N.kg-1.4 h-1, P < .05). Despite these relative agreements, absolute rates of whole-body amino acid oxidation were 25% (reciprocal pool model) to 43% (primary pool model) lower than when estimated from urea N appearance.(ABSTRACT TRUNCATED AT 250 WORDS)
We determined whether the amount of protein in the diet can affect insulin requirements in subjects with diabetes mellitus and glucose metabolism in normal subjects. Seven normal-weight volunteers with uncomplicated, intensively controlled, type I (insulin-dependent) diabetes and 12 similar nondiabetic subjects were studied on a metabolic ward before and after consuming a maintenance-energy but protein-free diet for 10 days. Blood glucose levels of diabetic subjects were measured seven times daily in response to insulin administration by continuous subcutaneous infusion. The plasma glucose appearance rate (Ra) was measured in seven normal subjects and all diabetic subjects using a primed-continuous infusion of D-[6,6-2H2]glucose. After adaptation to the protein-restricted diet, diabetic subjects experienced a 30% decrease in average preprandial and average daily blood glucose concentrations (P < .01); this occurred despite a concurrent 25% decrease in both basal and bolus insulin dosages (P < .001). Protein restriction decreased the postabsorptive glucose Ra (P < .05) and insulin concentrations (P < .01) of normal subjects by 20%, and increased their fasting glucagon concentrations by 24% (P < .01). We conclude that severe protein restriction decreases insulin requirements in type I diabetes and fasting hepatic glucose output and basal insulin levels in normal subjects. This effect appears to be mediated in part by decreased hepatic gluconeogenesis, but a contributory influence of increased insulin sensitivity is not ruled out.
The mechanism governing short-term adaptation to dietary protein restriction was investigated in nine normal adults by measuring their metabolic response to a standard mixed meal, first while they were adapted to a conventional, high-protein diet (day 1) and then again after they had eaten two low-protein meals (day 2). Urea appearance (measured as the sum of its urinary excretion and the change in body urea pool size), body retention of 15N-alanine included in each test meal, and whole-body protein turnover were calculated over the 9 hours following meal consumption on each day. Postprandial urea nitrogen appearance was 5.05 +/- 0.26 g/9 h on day 1 and decreased to 4.16 +/- 0.31 on day 2 (P < .05). Whole-body N flux (Q), protein synthesis (S), and protein breakdown (B) all decreased significantly on day 2 as assessed using either urea or ammonium end-product enrichments; however, recovery of 15N in the test meal as 15N-urea was similar on both days, approximately 22%. It is concluded that short-term metabolic adaptation occurs within two meals of reduced protein intake. The mechanism appears not to involve selectively an increased "first-pass" retention of dietary amino acids, but rather a general reduction in fed-state whole-body protein breakdown.
Plasma concentrations of the branched-chain amino acids leucine, isoleucine and valine, and those of leucine's and isoleucine's transamination products alpha-ketoisocaproic acid (KICA) and alpha-keto-beta-methylvaleric acid (KMVA), respectively, are known to increase after a protein meal or during extended fasting, but little or no increase in the concentration of valine's transamination product, alpha-ketoisovaleric acid (KIVA), has been observed under these conditions. To determine whether this could be explained by the conversion of KIVA to its alpha-hydroxy analogue, we measured the plasma concentrations of KICA, KMVA and KIVA, as well as their alpha-hydroxy analogues [alpha-hydroxyisocaproic acid (HICA), alpha-hydroxy-beta-methylvaleric acid (HMVA) and alpha-hydroxyisovaleric acid (HIVA)], in normal volunteers immediately after a protein meal or during a 60-h fast. We also determined the oxidoreduction equilibrium constants for HIVA/KIVA and HICA/KICA and their extent of plasma protein binding. In subjects in the postabsorptive state, the plasma concentrations of KICA and KMVA were 100 times those of HICA and HMVA, whereas that of KIVA was only twice that of HIVA. Shortly after a protein meal, KICA and KMVA concentrations increased significantly by 30 and 60%, respectively, whereas that of KIVA decreased by 25% (P < 0.05). HICA, HMVA and HIVA concentrations did not change. During prolonged fasting the plasma concentrations of all six metabolites increased gradually. The high plasma keto/hydroxy acid ratios were not related to their K(eq), which favored alpha-hydroxy analogue formation. The reduction of the branched-chain alpha-keto acids to their alpha-hydroxy analogues seems to take place too slowly to attain thermodynamic equilibrium.(ABSTRACT TRUNCATED AT 250 WORDS)
Authorities in the United States and Canada have recently advised persons with diabetes to limit their protein intake to the level recommended for normal adults, and consider further reductions in the presence of incipient renal disease. This recommendation ignores metabolic data indicating that conventional insulin therapy fails to fully normalize the abnormal protein metabolism characteristic of untreated diabetes. The residual abnormality is an increased or poorly regulated rate of amino acid catabolism. It is proposed in this review that the large amount of protein in the customary diet compensates for this increased amino acid catabolism, and thus protects many diabetic individuals from protein malnutrition. If this is true, protein restriction to a level that still meets the requirement of an individual with normal insulin metabolism could be too little for someone with diabetes. The current assumption that the protein requirement in diabetes is equal to the value set for normal individuals should be reconsidered.
Diminished gating of the P50 auditory evoked response to repeated stimuli is a psychophysiological feature of schizophrenia, that is also present in many relatives of patients. Animal models of auditory sensory gating indicate that nicotinic cholinergic neurotransmission is a critical neuronal substrate. The aim of this experiment was to determine if the deficit in sensory gating could be reversed by nicotine administration. Nonsmoking relatives of schizophrenics with abnormal sensory gating were selected as subjects for this initial double-blind trial, to avoid effects of psychotropic medications that might complicate trials in schizophrenic patients themselves. Nicotine-containing gum increased P50 sensory gating to near normal levels within 30 min of administration. The effect was transient; the gating of P50 returned to baseline levels within 1 hr. There was no change observed after placebo administration. In one of the subjects, the anticholinesterase inhibitor physostigmine similarly normalized P50 gating. The results are consistent with the hypothesis that nicotinic cholinergic neurotransmission may mediate a familial psychophysiological deficit in schizophrenia.
We postulated that the return to nitrogen equilibrium after 3 wk of a negative balance during a very-low-calorie diet (VLCD) providing low-quality protein in obese subjects was due to availability of endogenously originating amino acids from a "pool" that, when depleted, would result in worsening balance. This should be reflected in altered kinetics of protein metabolism with the requirement for increased breakdown to maintain synthesis constant. Seven female obese subjects [body mass index (BMI) = 34.4 +/- 1.8 kg/m2] were given a 1.7-MJ/d all-protein diet (16.8 g N) derived from hydrolyzed gelatin (supplemented with tryptophan and methionine) that provides 18% of its amino acids as essential, a multivitamin-mineral supplement, and 16 mmol KCl for 42 d. At baseline (7-d isocaloric diet), and weeks 4 and 6 of VLCD, amino nitrogen flux rate was calculated from the 15N abundance in urinary urea using the oral 15N-glycine method and rates of synthesis (S) and breakdown (B) inferred from N flux. Whole-body N flux did not change from baseline to weeks 4 and 6 (39.5 +/- 2.0 vs 37.4 +/- 2.0 vs 39.2 +/- 1.9 g N/d). By contrast, S and B decreased at weeks 4 and 6 with S decreasing more so that net protein synthesis (S-B) was less positive at week 4 than at baseline (2.2 +/- 0.2 and 0.9 +/- 0.3 g N/d; P less than 0.05) and became negative at week 6 (-0.9 +/- 0.2 g N/d; P less than 0.05). Concurrently, N equilibrium was achieved by week 4 but returned to negative balance by week 6.(ABSTRACT TRUNCATED AT 250 WORDS)
We tested the possibility that protein consumption greater than needed for optimum growth of young adult rats might increase either their hepatic glutathione (GSH) content or plasma GSH turnover. Additional aims were to characterize the relationship between hepatic GSH content and plasma turnover under physiologic conditions and to evaluate the ability of values obtained by noninvasive blood sampling to accurately predict hepatic GSH content. Male Sprague-Dawley rats (300 g) were adapted to purified diets containing 0, 5, 10, 20 or 40% casein. Plasma GSH and amino acid concentrations, hepatic GSH content and [35S]GSH-determined plasma GSH turnover were measured in the anesthetized, intact animals. As dietary protein increased from 0 to 20% casein, liver weight and liver GSH concentration (mumol/g wet wt) both increased. In rats fed the 40% casein diet, liver weight increased even further while liver GSH concentration decreased, with the net result that total liver GSH content of the 40% casein-fed group was not significantly different from that of the 20% casein-fed group. Plasma urea, cysteine, methionine and GSH concentrations increased with increasing protein intake, but with the exception of plasma urea, which increased by 60%, there was no further increase at the 40% casein level. Plasma GSH turnover also increased as dietary casein increased from 0 to 20% but was not significantly increased further by the 40% casein diet. A sigmoid function best described the relationship between plasma GSH turnover and hepatic GSH content (r = 0.80, P less than 0.0001).(ABSTRACT TRUNCATED AT 250 WORDS)
It is well known that inadequate insulin therapy stimulates body protein loss in insulin-dependent diabetes mellitus (IDDM). It is less well known, however, that accelerated body protein loss (as indicated by increased leucine oxidation) occurs in IDDM even during conventional glycemic control. It is not known whether intensified insulin therapy fully normalizes protein oxidation or, more importantly, whether such therapy is sufficient to allow the adaptive decrease of protein oxidation that normally occurs when protein intake is restricted below the customary surfeit level. We used two measures of protein oxidation [daily urinary nitrogen (N) excretion over several days of intensive insulin therapy and plasma [1-13C]leucine oxidation during short-term strict euglycemia] to assess the response of 7 men with IDDM and 12 normal men after adaptation first to a control diet providing maintenance energy and conventional (surfeit) protein then to an isoenergetic protein-free diet. After adaptation to the protein-free diet and during short-term strict euglycemia achieved using intravenous insulin, leucine turnover and oxidation decreased equivalently in normal and diabetic subjects. However, daily urinary obligatory N excretion, which indicated the effect of the low-protein diet and intensive subcutaneous insulin therapy over several days, was increased by 18% in the diabetic group (P less than 0.05). Even mildly elevated average blood glucose values well within the guidelines for intensive therapy were strongly correlated with high rates of urinary N excretion (r = 0.97, P = 0.0002). Thus insulin therapy of IDDM that imposes strict euglycemia is compatible with a normal ability to diminish body protein oxidation in response to protein restriction.(ABSTRACT TRUNCATED AT 250 WORDS)